[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_13603 

# __Delays in authorization of clinical trials and studies by national regulatory bodies__

## Articles mentionning the risk

* [Tacconelli_challenges_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_550.md)

## Mitigations of this risk

* [Establishing streamlined processes and communication channels with regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_15528.md)

## Name of the risk

Slower development of medical solutions and treatments for COVID-19

## People affected by this risk

* [Medical professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_425.md)

## Stakeholders who can mitigate this risk

* [Health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_422.md)
* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)

## Technologies linked to the risk

* [Digital collaboration platforms and electronic document submission systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_15897.md)

## This Risk belongs to this RiskGroup

* [Political risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_0.md)

## This Risk belongs to this RiskSubgroup

* [Weak local decision-making mechanisms](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_0.md)

